E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma

	E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma
刊名	CHINESE MEDICAL JOURNAL
	2011
卷号	124
关键词	GENE-THERAPY INTERFERON-ALPHA IN-VIVO CANCER SUNITINIB ONYX-015 MODEL TRIAL oncolysis adenovirus gemcitabine renal cell carcinoma
ISSN号	0366-6999
其他题名	E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma
英文摘要	Background Our previous studies have demonstrated potent oncolysis efficacy of the E1A, E1B double-restricted replication-competent oncolytic adenovirus AxdAdB-3 for treatment of bladder cancer. Here, we reported the feasibility and efficacy of AxdAdB-3 alone, or in combination with gemcitabine for treating renal cell carcinoma.
资助项目	[Qianjiang Program of Zhejiang Province]
语种	英语
CSCD记录号	CSCD:4428515
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/49843]
专题	中国科学院合肥物质科学研究院
推荐引用方式 GB/T 7714	. E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma[J]. CHINESE MEDICAL JOURNAL,2011,124.
APA	(2011).E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma.CHINESE MEDICAL JOURNAL,124.
MLA	"E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma".CHINESE MEDICAL JOURNAL 124(2011).